Your browser doesn't support javascript.
loading
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.
Tesori, Valentina; Piscaglia, Anna Chiara; Samengo, Daniela; Barba, Marta; Bernardini, Camilla; Scatena, Roberto; Pontoglio, Alessandro; Castellini, Laura; Spelbrink, Johannes N; Maulucci, Giuseppe; Puglisi, Maria Ausiliatrice; Pani, Giovambattista; Gasbarrini, Antonio.
Afiliação
  • Tesori V; Institute of Internal Medicine and Gastroenterology, Catholic University of the Sacred Heart School of Medicine.
  • Piscaglia AC; Institute of Internal Medicine and Gastroenterology, Catholic University of the Sacred Heart School of Medicine.
  • Samengo D; Institute of General Pathology, Laboratory of Cell Signaling, Catholic University of the Sacred Heart School of Medicine.
  • Barba M; Institute of Human Anatomy and Cell Biology, Catholic University of the Sacred Heart School of Medicine.
  • Bernardini C; Institute of Human Anatomy and Cell Biology, Catholic University of the Sacred Heart School of Medicine.
  • Scatena R; Institute of Biochemistry and Clinical Biochemistry, Catholic University of the sacred Heart School of Medicine.
  • Pontoglio A; Institute of Biochemistry and Clinical Biochemistry, Catholic University of the sacred Heart School of Medicine.
  • Castellini L; Department of Radiation Oncology, Center for Clinical Sciences Research, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Spelbrink JN; Department of Pediatrics, Nijmegen Centre for Mitochondrial Disorders, Radboud University Medical Centre, Geert Grooteplein 10, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands; Institute of Biomedical Technology &Tampere University Hospital, Pirkanmaa Hospital District, University of Tampere, F
  • Maulucci G; Institute of Physics, Catholic University of the Sacred Heart School of Medicine.
  • Puglisi MA; Institute of Internal Medicine and Gastroenterology, Catholic University of the Sacred Heart School of Medicine.
  • Pani G; Institute of General Pathology, Laboratory of Cell Signaling, Catholic University of the Sacred Heart School of Medicine.
  • Gasbarrini A; Institute of Internal Medicine and Gastroenterology, Catholic University of the Sacred Heart School of Medicine.
Sci Rep ; 5: 9149, 2015 Mar 17.
Article em En | MEDLINE | ID: mdl-25779766
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2015 Tipo de documento: Article